Exposure to pyrithiamine increases β-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain (Q48157530)

9 February 2018

title

Exposure to pyrithiamine increases β-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain (English)

1 reference

9 February 2018

main subject

pyrithiamine bromide

1 reference

ChEBI release 2020-05-28

Jing Zhao

1

1 reference

9 February 2018

Xiaojing Sun

2

1 reference

9 February 2018

Zhe Yu

3

1 reference

9 February 2018

Xiaoli Pan

4

1 reference

9 February 2018

Fenghua Gu

5

1 reference

9 February 2018

Jia Chen

6

1 reference

9 February 2018

Wenxin Dong

7

1 reference

9 February 2018

Lei Zhao

8

1 reference

9 February 2018

Chunjiu Zhong

9

1 reference

9 February 2018

publication date

22 June 2010

1 reference

9 February 2018

published in

Neurotoxicity Research

1 reference

9 February 2018

volume

19

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

575-583

1 reference

9 February 2018

Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Thiamine deficiency and wernicke's encephalopathy in AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

GSK-3: tricks of the trade for a multi-tasking kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Clinical characteristics and MR imaging features of nonalcoholic Wernicke encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Targeting glycogen synthase kinase-3 in insulin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Mouse models of Alzheimer's disease: insight into treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Thiamine-dependent processes and treatment strategies in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Plasma and red blood cell thiamine deficiency in patients with dementia of the Alzheimer's type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Positron emission tomography imaging in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Pyrithiamine as a substrate for thiamine pyrophosphokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Elevated cerebrospinal fluid tau protein levels in Wernicke's encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Brain mitochondrial metabolism in experimental thiamine deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Development of Wernicke-Korsakoff syndrome after long intervals following gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Decreased transketolase activity contributes to impaired hippocampal neurogenesis induced by thiamine deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12640-010-9204-0

21 January 2018

12 December 2020

Judging a protein by more than its name: GSK-3.

1 reference

12 December 2020

Is thiamine deficiency in elderly people related to age or co-morbidity?

1 reference

12 December 2020

Thiamine deficiency after feeding pyrithiamine

1 reference

12 December 2020

The mode of action of pyrithiamine as an inductor of thiamine deficiency

1 reference

12 December 2020

Low energy levels in thiamine-deficient encephalopathy.

1 reference

12 December 2020

Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.

1 reference

12 December 2020

Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease.

1 reference

12 December 2020

Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration

1 reference

12 December 2020

Molecular cloning and expression of glycogen synthase kinase-3/factor A

1 reference

12 December 2020

GSK-3 is essential in the pathogenesis of Alzheimer's disease.

1 reference

12 December 2020

Thiamine deficiency increases β-secretase activity and accumulation of β-amyloid peptides

1 reference

12 December 2020

10.1007/S12640-010-9204-0

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018